UCSD Announces Alzheimer’s Disease Research Breakthrough: Obj-SCD Predicts Amyloid Accumulation & Neurodegeneration

University of California, San Diego School of Medicine, and Veterans Affairs San Diego Healthcare System researchers report discovering that the accumulation of amyloid, the abnormal protein linked to neurodegenerative conditions such as Alzheimer’s disease (AD),...

Green Valley’s Oligomannate Approved for Alzheimer’s Disease Treatment in China Representing the First AD Approval in Decades

Shanghai China’s Green Valley Pharmaceuticals (Green Valley) received approval from the China National Medical Products Administration (NMPA) for their Oligomannate (GV-971) as a new drug for the treatment of mild to moderate Alzheimer’s disease (AD) and improving...

Pin It on Pinterest